Recombinant Human Erythropoietin to Correct Uremic Bleeding
Authors:
- Ariela BenigniABAriela Benigni
- Daniela MendogniDMDaniela Mendogni
- Giulio MingardiGMGiulio Mingardi
- Giuliano MeccaGMGiuliano Mecca
- Giuseppe RemuzziGiuseppe Remuzzi
- 1 July 1991
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 18 (1) , 44-49
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Statement on the Clinical Use of Recombinant Erythropoietin in Anemia of End-Stage Renal DiseaseAmerican Journal of Kidney Diseases, 1989
- Treatment of Renal Anemia with Recombinant Human ErythropoietinAmerican Journal of Nephrology, 1989
- BLEEDING IN RENAL FAILUREThe Lancet, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusionsBritish Journal of Haematology, 1985
- Uremia as a Cause of BleedingAmerican Journal of Nephrology, 1985
- URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONSThe Lancet, 1982
- Bleeding time in Uremia: A useful test to assess clinical bleedingAmerican Journal of Hematology, 1979